The FDA is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years of age.
JANUARY 12, 2018
FDA Revises Cough and Cold Product Labeling to Limit Pediatric Use